Clinical and Economic Aspects of Prophylaxis and Treatment of Pneumocystis carinii Pneumonia Kenneth A. Freedberg Guest Editorial 15 November 2012 Pages: 95 - 98
Preventing NSAID-Induced Gastrointestinal Toxicity Gérard de Pouvourville Leading Article 15 November 2012 Pages: 99 - 110
The Economics of Mail Service Pharmacy Albert I. WertheimerKnte B. Andrews Leading Article 15 November 2012 Pages: 111 - 118
Clinical and Economic Factors in the Treatment of Congestive Heart Failure Richard AndrewsAlan J. Cowley Review Article 15 November 2012 Pages: 119 - 127
Epidemiology, Therapy and Costs of Nosocomial Infection Ramón Gálvez-VargasAurora Bileno-CavanillasMiguel García-Martín Review Article 15 November 2012 Pages: 128 - 140
Quality-of-Life Measurements for Patients Taking Which Drugs? Per Bech Review Article 15 November 2012 Pages: 141 - 151
Research and Development Costs for New Drugs by Therapeutic Category Joseph A. DiMasiRonald W. HansenLouis Lasagna Original Research Article 15 November 2012 Pages: 152 - 169
Societal Perspective on the Burden of Migraine in The Netherlands Leona van RoijenMarie-Louise Essink-BotFrans F. H. Rutten Original Research Article 15 November 2012 Pages: 170 - 179
The System of Objective Judgement Analysis Method: Less Objectivity Than Pretended? Peter SchachtDietrich BosseRobert Janknegt Correspondence 15 November 2012 Pages: 180 - 182